Portfolio

Noema Pharma

CEO Ilise Lombardo

Noema Pharma's pipeline contains novel therapies designed to address debilitating central nervous system (CNS) disorders in order to improve quality of life and patient outcomes.

Noema Pharma's pipeline contains novel therapies designed to address debilitating central nervous system (CNS) disorders in order to improve quality of life and patient outcomes.

The company partners with patients, families and caregivers, and healthcare professionals to provide a comprehensive approach beyond treating symptoms to ensure that patients’ experiences, perspectives, needs, and priorities are meaningfully incorporated into our work.

Human Health

Noema Pharma logo

Industry

Biotech

Status

Current